Results 191 to 200 of about 59,431 (239)

Targeting and Suppression of Survivin in Cancer Cells Based on the Interaction of Cell Surface Vimentin with <i>N</i>‑Acetylglucosamine-Bearing Polymers. [PDF]

ACS Omega
Kitagawa K, Kobayashi S, Miura Y, Tanaka M, Ise H.   +4 more
europepmc   +1 more source

Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma. [PDF]

Blood Adv
Toner K, Renfro LA, Dave H, Pezzella G, Pei Q, Giulino-Roth L, Horton T, Keller FG, Kelly KM, Castellino SM, Bollard CM.   +10 more
europepmc   +1 more source

Synergistic Anticancer Effects of Metformin and Doxorubicin in Ovarian Cancer Cells Through Dual Apoptotic Pathway Activation and Oxidative Stress Enhancement. [PDF]

Biology (Basel)
Alkan Akalın S, Afşin Y, Toprak V, Özdemir İ, Tuncer MC, Öztürk Ş.   +5 more
europepmc   +1 more source

Therapeutic efficacy of oncolytic adenovirus YSCH-01 in osteosarcoma evaluated in PDX and CDX mouse models. [PDF]

Sci Rep
Jin H, Chen R, Wang Y, Huang J, Cao XP, Raza HK, Fang XL, Zhang KJ, Li N, Zhou S, Yang Q.   +10 more
europepmc   +1 more source

Dual inhibition of MAPK and TORC1 signaling retards development of radiation resistance in pediatric BRAFV600E glioma models. [PDF]

Neuro Oncol
Li F, Bondra KM, Wang H, Kurmashev D, Mukherjee B, Kanji S, Habib AA, Chen Y, Zheng S, Burma S, Houghton PJ.   +10 more
europepmc   +1 more source

[Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells. [PDF]

Oncol Rep
Tang C, Hahm E, Bae S, Kang JS, Lee WJ.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Survivin and Leukemia

International Journal of Hematology, 2004
Survivin is a unique member of the inhibitor-of-apoptosis family. Survivin plays a role in the proliferation and survival of normal hematopoietic cells. Survivin expression is aberrantly enhanced in most cancers and hematopoietic malignancies. Survivin is an attractive therapeutic target, and various approaches to targeting survivin have been tested in
Xiu Li, Cong, Zhong Chao, Han
openaire   +2 more sources

Survivin in liver

Gastroenterology, 2003
Abstract Readers are encouraged to write letters to the editor concerning articles that have been published in Gastroenterology. Short, general comments are also considered, but use of the Correspondence section for publication of original data in preliminary form is not encouraged.
Katsuya, Shiraki, Takeshi, Nakano, Hisashi, Hisatomi   +2 more
openaire   +2 more sources

Survivin in autoimmune diseases

Autoimmunity Reviews, 2017
Survivin is a protein functionally important for cell division, apoptosis, and possibly, for micro-RNA biogenesis. It is an established marker of malignant cell transformation. In non-malignant conditions, the unique properties of survivin make it indispensable for homeostasis of the immune system.
G, Gravina, C, Wasén, M J, Garcia-Bonete, M, Turkkila, M C, Erlandsson, S, Töyrä Silfverswärd, M, Brisslert, R, Pullerits, K M, Andersson, G, Katona, M I, Bokarewa   +10 more
openaire   +2 more sources